Product Program year 2025 Source: CMS Open Payments

Symplicity G3

Device Renal Denervation System

PDI 00643169615984

Open in the dashboard

General payments

$3,013,212

21,368 payments

Research payments

$32,734,141

1,930 payments

Through program year 2025, $3,013,212 in general payments and $32,734,141 in research payments were reported against Symplicity G3 (Renal Denervation System).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

6 rows
Year Kind Amount Payments
2025 General $2,126,295 13,222
2025 Research $12,426,900 730
2024 General $820,750 7,718
2024 Research $16,566,101 693
2023 General $66,167 428
2023 Research $3,741,140 507

Breakdown

Who paid General payments · program years 2023–2025
  1. Medtronic, Inc. $3,013,212 21,368 payments
Top recipients General payments · program year 2025
  1. Beth Israel Deaconess Medical Center Teaching hospital · MA $68,440 3% · 4 payments
  2. Barry Bertolet Cardiovascular Disease · Tupelo, MS $62,494 3% · 88 payments
  3. Taisei Kobayashi Interventional Cardiology · Philadelphia, PA $58,050 3% · 72 payments
  4. Michael Bloch Internal Medicine · Reno, NV $56,888 3% · 49 payments
  5. Jeremy Bock Interventional Cardiology · Leesburg, VA $42,168 2% · 64 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Interventional Cardiology Internal Medicine $877,313 46% · 1,316 practitioners
  2. Cardiovascular Disease Internal Medicine $524,778 27% · 1,109 practitioners
  3. Internal Medicine $155,151 8% · 354 practitioners
  4. Nephrology Internal Medicine $100,835 5% · 140 practitioners
  5. Nurse Practitioner, Family Nurse Practitioner $60,466 3% · 471 practitioners

The top 5 of 84 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Pennsylvania $190,778 9% · 269 recipients
  2. California $165,249 8% · 533 recipients
  3. Florida $154,538 7% · 384 recipients
  4. New York $153,794 7% · 436 recipients
  5. Texas $120,435 6% · 512 recipients

The top 5 of 51 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

21,368 general · 1,930 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record